To determine whether the TIA1-dependent, anti-glycolytic effect we observed in vitro also operates in a physiologically intact, immune-competent setting, we turned to an orthotopic MB49-Luc bladder tumor model in C57BL/6J mice. This evidence concerns the gene TIA1 and urinary bladder neoplasm.